| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Sevre-Long 120 mg, Kapseln retard | | 53952 | | 04 | | Sevre-Long 120 mg | | Kapseln retard | | N02AA01 | | Morphine | | 30.01.1997 | | |
| | Composition | | morphini sulfas pentahydricus 120 mg corresp. morphinum 90.25 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 172 (nigrum), E 172 (flavum), E 171, natrii laurilsulfas corresp. natrium 0.012 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula. | | Packungsbestandteile | | Delayed release capsules | | | | | Active Agent | Dose |
|---|
| Morphine Sulfate Pentahydrate | 120 mg correspond Morphine 90.25 mg |
| | BAG: Active Agent | Dose |
|---|
| Morphini Sulfas Pentahydricus (2:1) | 120 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | E 132 | | Kapselhülle | | E 171 | | color. | | E 172 | | color. | | Gelatina | | | | Lacca | | Drucktinte | | Macrogol | 6000 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Oleum Vegetabile Hydrogenatum | | | | Pro Capsula | | | | Propylenglycol | | | | Talcum | | |
| |
| |
|
